In this issue:
Diagnosis and classification of diabetes: Standards of Care 2026
Menopause Practice Standards
WHO guideline on glucagon-like peptide-1 therapies for obesity
Clinical guidance for transition from paediatric to adult endocrine care
Pharmacologic treatment of obesity in adults: Standards of Care
Management guidelines for adult patients with differentiated thyroid cancer
Polyendocrine metabolic ovarian syndrome replaces the name polycystic ovary syndrome
Pharmaceutical Benefits Advisory Committee (PBAC) meeting outcomes March 2026
Australasian Menopause Society (AMS) welcomes national awareness campaign
Weight loss: Friend or foe for bone and muscle?
Ketogenic vs. low-fat diets for T2D remission
Defining disease or delaying care? The Lancet obesity framework
Conferences, workshops and CPD
Please login below to download this issue (PDF)